Chr. Hansen reports strong organic growth of 14% for Q2 in a challenging environment
https://www.chr-hansen.com/en/media/press-releases/2022/4/chr-hansen-reports-strong-organic-growth-of-14-for-q2-in-a-challenging-environment
Continued solid growth in Food Cultures & Enzymes driven by core segments and accelerated growth in Health & Nutrition; 2021/22 outlook adjusted in response to market volatility and accelerating inflationary pressure

Organic growth is expected in the range of 7-11%
EBIT margin before special items is expected to be 26-27%
Free cash flow before special items is expected to be around EURm 140-170

Vedhaeftet et par figurer. Klik paa billedet for at goere det stoerre.